右美托咪定促进结直肠手术患者术后恢复:随机对照试验的系统综述与荟萃分析
该系统综述与荟萃分析检索截至2023年9月的CENTRAL、Emcare、Embase和MEDLINE,纳入8项随机对照试验,比较成人择期结直肠手术中右美托咪定与对照组的术后胃肠功能。右美托咪定组570例,对照组556例;右美托咪定缩短首次排气、首次排便、首次固体口服摄入时间和住院时间,证据确定性从极低到中等。
要点
- 右美托咪定缩短择期结直肠手术患者首次排气时间(MD -4.55 h)。
- 右美托咪定缩短首次固体口服摄入时间(MD -4.34 h),证据确定性中等。
核心结论
- 成人择期结直肠手术术中应用右美托咪定可改善术后胃肠功能并缩短住院时间,可作为促进术后恢复的辅助手段。
研究设计与样本
- 系统综述与荟萃分析,检索CENTRAL、Emcare、Embase和MEDLINE至2023年9月,纳入8项随机对照试验。
- 右美托咪定组570例(平均年龄65.8岁,女性43%,平均BMI 22.7 kg/m2),对照组556例(平均年龄70.6岁,女性40%,平均BMI 22.5 kg/m2)。
主要发现
- 右美托咪定缩短首次排气时间(MD -4.55 h,95% CI: 20.14-8.95,p < 0.005,证据确定性极低)。
- 右美托咪定缩短首次排便时间(MD -11.9 h,95% CI: 18.74-5.05,p < 0.005,证据确定性极低)。
- 右美托咪定缩短首次固体口服摄入时间(MD -4.34 h,95% CI: 17.43-11.24,p < 0.005,证据确定性中等)。
临床怎么用
- 对成人择期结直肠手术患者,可考虑术中应用右美托咪定以促进术后胃肠功能恢复和缩短住院时间。
- 应用时需结合证据确定性(多数结局为极低确定性)和患者个体情况综合决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intraoperative administration of dexmedetomidine has shown promise in improving postoperative gastrointestinal function. In the context of colorectal surgery, the results remain inconsistent. This review aims to provide a synthesis of studies assessing the effect of dexmedetomidine on postoperative gastrointestinal function in colorectal surgery patients. METHODS: CENTRAL, Emcare, Embase, and MEDLINE were searched up to September 2023. Randomized controlled trials involving adult patients (≥ 18 years) undergoing elective colorectal surgery, comparing dexmedetomidine administration to a control group, and reporting on postoperative gastrointestinal function were included. Non-comparative and emergent procedures were excluded. Primary outcome was time to first flatus or bowel movement, and secondary outcomes included length of stay and time to solid oral intake. Risk of bias was assessed using the Cochrane risk of bias tool for randomized studies. RESULTS: After screening 1194 citations, eight studies were included. Studies comprised of 570 patients in the dexmedetomidine group (mean age: 65.8 years, 43% female, mean BMI: 22.7 kg/m2) and 556 patients in control group (mean age 70.6 years, 40% female, mean BMI 22.5 kg/m2). Dexmedetomidine administration resulted in a shorter time to flatus (MD -4.55 h, 95% CI: 20.14-8.95, p < 0.005, very low certainty of evidence), a shorter time to first bowel movement (MD -11.9 h, 95% CI: 18.74-5.05, p < 0.005, very low certainty of evidence), a shorter time to solid oral intake (MD -4.34 h, 95% CI: 17.43-11.24, p < 0.005, moderate certainty of evidence), and a shorter length of stay (MD -.06 days, 95% CI: 1.99-0.12, p < 0.05, very low certainty of evidence). CONCLUSION: In adult patients undergoing elective colorectal surgery, intraoperative use of dexmedetomidine results in clinically meaningful improvements in postoperative gastrointestinal function and consequently, shorter length of stay. Therefore, dexmedetomidine may serve as a valuable adjunct in enhancing postoperative recovery of patients following elective colorectal surgery, thereby reducing healthcare utilization, and improving patient outcomes.
引用
- Sharma S, Khamar J, Petropolous JA, et al. Postoperative recovery of colorectal patients enhanced with dexmedetomidine (PReCEDex): a systematic review and meta-analysis of randomized controlled trials. Surg Endosc. 2024. PMID: 39060623. doi:10.1007/s00464-024-11060-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。